ArticleOncotarget2017

Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells.

Paola Bagnato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.